Persistent Microfilaremia Caused by Dirofilaria asiatica Infection in Child, Sri Lanka, 2024

What is established Filarial nematodes are parasitic worms responsible for significant human diseases globally, especially in tropical regions. Several species, such as Wuchereria bancrofti and Brugia spp., cause lymphatic filariasis, while others produce subcutaneous or ocular filariases. The World Health Organization estimates more than 650 million people remain at risk for lymphatic…

Fatal Rickettsia parkeri Rickettsiosis in Immunocompromised Pediatric Patient, Georgia, USA, 2025

Evidence Dossier: Fatal Rickettsia parkeri Rickettsiosis in Immunocompromised Pediatric Patient Fatal Rickettsia parkeri Rickettsiosis in an Immunocompromised Pediatric Patient: Evidence Dossier This dossier summarizes and assesses the evidence from a 2026 case report published in the Emerging Infectious Diseases Journal concerning a fatal infection by Rickettsia parkeri in a 3-year-old child undergoing…

Post–COVID-19 Expansion of Streptococcus pyogenes Lineages Causing Toxic Shock Syndrome, Japan, 2023–2024

Evidence Dossier: Expansion of Streptococcus pyogenes Lineages Causing Toxic Shock Syndrome in Post-COVID-19 Japan What is established Streptococcus pyogenes, specifically group A Streptococcus (GAS), is known to cause streptococcal toxic shock syndrome (STSS), a rapidly progressing and often fatal invasive bacterial infection. Before the COVID-19 pandemic and associated interventions, various lineages of…

Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 21, Status: Authorised

Evidence Dossier: Cibinqo (abrocitinib) for Atopic Dermatitis What is established Cibinqo, containing the active substance abrocitinib, is a medicine authorised in the European Union since December 2021 for the treatment of moderate to severe atopic dermatitis (eczema) in adults and adolescents aged 12 years and older. It is indicated for patients where…

Communicable disease threats report, 10 – 16 October, week 42

Health & Science Evidence Dossier: Communicable Disease Threats in Europe, 10 – 16 October 2026 This dossier summarizes information from the European Centre for Disease Prevention and Control’s (ECDC) weekly Communicable Disease Threats Report (CDTR) for week 42 of 2026, covering the period 10 to 16 October. The CDTR is aimed at…

F1’s Rwanda Race Could Be Bad News for Rights

F1’s Rwanda Race and Its Implications for Human Rights: An Evidence Dossier What is Established Formula One has signed a 10-year agreement to host a Grand Prix race in Rwanda, starting in the early 2030s. This move marks a significant expansion for the sport into Africa, offering increased continental visibility on the…

Syria: Women Barred from Defense, Security Colleges

What is established In October 2026, Syrian authorities introduced admissions rules barring women from most academic programs at two new state universities focused on defense and security. These restrictions prevent women from enrolling in land, naval, and air force military colleges, as well as humanities and administrative sciences at the National University…

Romanian Institutions Bought Banned Russian Cybersecurity Software

Accountability in the Romanian Procurement of Banned Russian Cybersecurity Software This evidence dossier examines the revelations reported by OCCRP on October 16, 2026, regarding Romanian public institutions’ purchases of cybersecurity products from Kaspersky, a Russian company, despite legal prohibitions. What is Established Romania has a legal framework enacted in 2022 explicitly banning…